Compugen | CGEN - Stammkapital





Stammkapital Veränderung Datum
Arca Biopharma USD 48.72M 338K 2025-12
aTyr Pharma USD 16.65M 81.34M 2025-12
Bio Path USD 9.24M 934K 2025-09
Brainstorm Cell Therapeutics USD 11.04M 2K 2025-12
Cara Therapeutics USD 9.38M 9.38M 2025-09
Clal Biotechnology ILS 1.61M 0 2022-12
Compugen USD 94.55M 1.02M 2025-12
Immunic USD 120.38M 21.73M 2025-12
Minerva Neurosciences USD 1000 0 2024-09
RedHill Biopharma USD 50.92B 17.62B 2025-12
TherapeuticsMD USD 11K 0 2023-09